1-8 of 8
Shanhao Tang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mid-treatment CSF ctdna and MYD88 clearance outperform PET-CT in predicting response and survival to orelabrutinib-based induction in newly diagnosed PCNSL: A prospective biomarker study

Free
Lixia Sheng, Yanli Lai, Sheng Nie, Yuning Pan, Di Wang, Shanhao Tang, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen, Guifang Ouyang
Journal: Blood
Blood (2025) 146 (Supplement 1): 59.
https://doi.org/10.1182/blood-2025-59
Published: 2025
Journal Articles

Efficacy and safety observation of luspatercept for refractory anemia associated with hematologic malignanciesluspatercept治疗血液系统恶性肿瘤相关难治性贫血的疗效和安全性观察luspatercept 改善与血液系统恶性肿瘤相关的难治性贫血的疗效和安全性：一项观察

Free
Ping Zhang, Shuling Yu, Shengfa Gao, Huiling Zhu, Shanhao Tang, Yongcheng Sun, Binbin Lai, Xiao Wu, Lieguang Chen, Kaihong Xu, Lixia Sheng, Guifang Ouyang
Journal: Blood
Blood (2025) 146 (Supplement 1): 2888.
https://doi.org/10.1182/blood-2025-2888
Published: 2025
Journal Articles

Multi-omics profiling of the gut Microbiota–Metabolism–Immunity axis reveals predictive biomarkers of treatment response and survival in diffuse large B-cell lymphoma

Free
Lixia Sheng, Changyu Jin, Huijie Hu, Yanli Lai, Huiying Qiu, Shasha You, Jiaping Wang, Shuyan Wang, Yan Xiong, Li Hu, Kaihong Xu, Ping Zhang, Yongcheng Sun, Lieguang Chen, Shanhao Tang, Xiao Wu, Yi Zhang, Qitian Mu, Tongyu Li, Xinjun Wang, Guifang Ouyang
Journal: Blood
Blood (2025) 146 (Supplement 1): 3533.
https://doi.org/10.1182/blood-2025-3533
Published: 2025
Journal Articles

Timed PD-1 blockade synergizes with IL-7/CCL19 armoring to reverse CAR-T exhaustion in PD-L1-high large B-cell lymphoma

Free
Lixia Sheng, Wen Lei, Duo Wu, Yi Zhang, Yanli Lai, Shuyan Wang, Duobing Zou, Ping Zhang, Kaihong Xu, Shanhao Tang, Huijie Hu, Tongyu Li, Qitian Mu, Xiaofei Ye, Hui Liu, Wenbin Qian, Guifang Ouyang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1929.
https://doi.org/10.1182/blood-2025-1929
Published: 2025
Journal Articles

A Prospective, Multicenter, Single-Arm Study on the Combination of Orelabrutinib and Rituximab in the Second-Line Treatment of Relapsed/Refractory Marginal Zone Lymphoma

Free
Guifang Ouyang, Lixia Sheng, Jiaping Wang, Hui Zeng, Shanhao Tang, Xibin Xiao, Yamin Tan, Qunyi Guo, Yanping Shao, Minchao Yan, Wenbin Qian
Journal: Blood
Blood (2024) 144 (Supplement 1): 4391.
https://doi.org/10.1182/blood-2024-198485
Published: 2024
Journal Articles

Preliminary Data on the Efficacy and Safety of Orelabrutinib Combined with Rituximab and Methotrexate (ORM Regimen) As First-Line Treatment for Primary Central Nervous System Lymphoma, and the Exploration of Cerebrospinal Fluid Ctdna Dynamic Monitoring

Free
Lixia Sheng, Guifang Ouyang, Yanli Lai, Sheng Nie, Di Wang, Shanhao Tang, Yuning Pan, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4500.
https://doi.org/10.1182/blood-2024-198355
Published: 2024
Journal Articles

Ikaros Family Zinc Finger 1 Mutation Is a Poor Prognosis Factor of Adult B Cell Acute Lymphoblastic Leukemia

Free
Shanhao Tang, Hongjie Shen, Xinliang Mao, MD PhD, Haiping Dai, Xiaming Zhu, Shengli Xue, Zixuan Ding, Jing Lu, Depei Wu, MD, XiaoWen Tang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5117.
https://doi.org/10.1182/blood.V130.Suppl_1.5117.5117
Published: 2017
Journal Articles

Prognostic Impact of FLT3-ITD and DNMT3A R882 Double Mutations in Patients with Acute Myeloid Leukemia

Free
Shanhao Tang, Xiaowen Tang, MD, Hongjie Shen, Shengli Xue, Tingjing Wang, Jing Lu, Jia Yin, Depei Wu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5244.
https://doi.org/10.1182/blood.V128.22.5244.5244
Published: 2016